openPR Logo
Press release

Antacid Market Evenly Poised To Reach A Market Value of US$ By Share, Size and Leading Players (J&J, GSK, Pfizer, AstraZeneca, Takeda Pharma, Bayer, Sanofi,) | Forecast to 2025

03-04-2021 01:30 PM CET | Health & Medicine

Press release from: Business Industry Reports

Antacid Market

Antacid Market

Global Antacid Market Synopsis:

The exclusive research report on the Global Antacid Market 2021-2025 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global Antacid Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

The most important key factors driving the growth of the Global Antacid Market are Changing dietary habits and increasing prevalence of Gastro-Esophageal Reflux Diseases (GERD). Additionally, increasing consumption of foods such as fried or fatty foods, citrus, and chocolate, coffee, carbonated beverages etc. which increase the gastric HCl content in stomach is resulting in adoption of antacid, thereby boosting growth of the market of antacid globally.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/283915 .

Significant points in table of contents: Market Definition, Market Overview, Business Introduction, Segmentation (Region Level), Segmentation (Type Level), Segmentation (Industry Level), Segmentation (Channel Level), Market Forecast Year, Segmentation Type, Segmentation Industry, Market Cost Analysis, and Conclusion. The Antacid Market is segmented based on Product, source, application and Regions. On the basis of product, the market is sub-segmented.

Regionally, APAC is expected to be the largest and fastest-growing regional segment during the forecast period owing to high unmet clinical needs, availability of effective treatment methods, rising disposable income, and consumer awareness about the availability of these products. North America is estimated to be the second-largest growing segment. This was attributed to increasing digestive disorder prevalence coupled with consumer awareness of antacid products.

Top Major Key Players in the Global Antacid Market:

1 AstraZeneca

2 Takeda Pharmaceutical

3 Pfizer

4 Reckitt Benckiser

5 Bayer

6 Procter Gamble

7 GlaxoSmithKline

8 Johnson & Johnson

9 CONBA

10 Xiuzheng Pharma

11 Sanofi

12 Bausch Health

13 CR SANJIU

14 Reddy's Laboratories and More………………….

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Antacid Market Report 2021” @ https://www.businessindustryreports.com/buy-now/283915/single .

Product Type Segmentation

1 Proton Pump Inhibitor

2 H2 Antagonist

3 Acid Neutralizers

Industry Segmentation

1 OTC Drug

2 Rx Drug

Top Medical Industry News:

U.S. FDA Expands Approval of Pfizer’s LORBRENA as First-Line Treatment for ALK-Positive Metastatic Lung Cancer - The U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s supplemental New Drug Application (sNDA) for LORBRENA (lorlatinib), expanding the indication to include first-line treatment of people with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). LORBRENA is now indicated for adults with metastatic NSCLC whose tumors are ALK-positive as detected by an FDA-approved test. The FDA action also converts the 2018 accelerated approval to full approval. The application was approved under the FDA’s Real-Time Oncology Review (RTOR) pilot program.

“For more than a decade, Pfizer has been a pioneer in delivering biomarker-driven therapies and addressing the diverse and evolving needs of people with non-small cell lung cancer,” said Andy Schmeltz, Global President, Pfizer Oncology. “LORBRENA has been a transformative medicine for people with ALK-positive advanced NSCLC, and this FDA approval in the first-line setting means that we can now extend hope to even more people.”

LORBRENA is a third-generation ALK inhibitor specifically designed to inhibit the most common tumor mutations that drive resistance to current medications and to address metastases in the brain, a frequent site for disease progression in ALK-positive NSCLC. Up to 40% of people with ALK-positive metastatic NSCLC present with brain metastases at initial diagnosis.

The expanded approval of LORBRENA is based on the results from the pivotal Phase 3 CROWN trial, which showed a 72% reduction in risk of progression or death vs. XALKORI (crizotinib) in a previously untreated patient population as assessed by blinded independent central review (BICR). Central nervous system (CNS) involvement was assessed in all patients. There were 17 patients in the LORBRENA arm and 13 in the XALKORI arm with measurable brain metastases based on baseline brain imaging. A prespecified exploratory analysis showed that among these patients, the intracranial objective response rate (IC-ORR), as assessed by BICR, was 82% (95% CI, 57 to 96) in the LORBRENA arm and 23% (95% CI, 5 to 54) in the XALKORI arm. The intracranial duration of response (IC-DOR) was 12 months or longer in 79% (n=11) and 0% of patients in the LORBRENA and XALKORI arms, respectively.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/283915 .

Major Points in Table of Contents:

Global Antacid Market Report 2021

1 Antacid Product Definition

2 Global Antacid Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Antacid Shipments

2.2 Global Manufacturer Antacid Business Revenue

2.3 Global Antacid Market Overview

2.4 COVID-19 Impact on Antacid Industry

3 Manufacturer Antacid Business Introduction

3.1 AstraZeneca Antacid Business Introduction

3.2 Takeda Pharmaceutical Antacid Business Introduction

3.3 Pfizer Antacid Business Introduction

3.4 Reckitt Benckiser Antacid Business Introduction

3.5 Bayer Antacid Business Introduction

3.6 J&J Antacid Business Introduction

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that hold the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antacid Market Evenly Poised To Reach A Market Value of US$ By Share, Size and Leading Players (J&J, GSK, Pfizer, AstraZeneca, Takeda Pharma, Bayer, Sanofi,) | Forecast to 2025 here

News-ID: 2252237 • Views:

More Releases from Business Industry Reports

Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo International, Nuvo Pharma, Ferndale Pharma, Galen, Jazz Pharma, Paladin Labs, St Renatus, MSK Pharma
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size and Leading Players (Lockheed Martin, BAE System, Boeing, General Dynamic, Raytheon) | Forecast to 2025
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market: This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization. According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growth by Top Key Company’s - J&J, Medtronic, B Braun, Boston Medical, Integra, Stryker, Zimmer, CONMED
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market: This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization. According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key Players - Apple, Fitbit, Synbiota, THE ODIN, HVMN, Thync Global, Moodmetric
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis: The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast

All 5 Releases


More Releases for Antacid

Antacid Market is Grabbing New opportunities by 2025
In its recently added report by Big Market Research has provided unique insights about Antacid Market for the given period. One of the main objectives of this report is to categorize the various dynamics of the market and to offer latest updates such as mergers and acquisitions, various technological developments, new entrants in the market, which make an impact on different segments. The comprehensive value chain analysis of the market will
Antacid Market Outlook and Major Regions' Development Status
In its recently added report by Big Market Research has provided unique insights about Antacid Market for the given period. One of the main objectives of this report is to categorize the various dynamics of the market and to offer latest updates such as mergers and acquisitions, various technological developments, new entrants in the market, which make an impact on different segments. The comprehensive value chain analysis of the market will
Antacid Suspensions Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Antacid Suspensions Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Antacid Suspensions players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Antacid Suspensions with respect to individual growth
Global Antacid Tablet Sales Market Report
In this report, the global Antacid Tablet market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Antacid Tablet for these regions, from 2013 to 2025
Global Antacid Tablet Sales Market Report
In this report, the global Antacid Tablet market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Antacid Tablet for these regions, from 2013 to 2025
Global Antacid Market Share, Size, Growth & Forecast 2021
The Global Antacid Market was worth USD 3,790 million in 2016 and estimated to be growing at a CAGR of 2.5%, to reach USD 4,290 million by 2021. The market is showcasing evident potential in the mentioned forecasting period. It is expected to show significant growth in coming years because of the people being habitual of indulging in poor eating habits and resultantly facing stomach problems. The number of cases